123 results
Page 3 of 7
8-K
EX-10.2
7gdellop5v9h ha
14 Dec 22
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
7:11am
8-K
EX-10.1
l2imuino1l1
14 Dec 22
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
7:11am
8-K
EX-10.1
vs55 g21llj0j4w5d5n
31 Oct 22
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-10.3
1s3mqzqqg 5g8dydd
27 Sep 22
Entry into a Material Definitive Agreement
7:13am
8-K
EX-10.1
i19ctsoql78z ii
27 Sep 22
Entry into a Material Definitive Agreement
7:13am
8-K
EX-10.2
c75h7ul62gzxn8t0l2
27 Sep 22
Entry into a Material Definitive Agreement
7:13am
8-K
EX-10.4
2zz56ln4ev39mtwu uc
27 Sep 22
Entry into a Material Definitive Agreement
7:13am
8-K
EX-10.2
ldmgg
13 May 22
Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium
4:12pm
8-K
EX-10.1
4mfrr ojx3
13 May 22
Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium
4:12pm
8-K
EX-10.3
ypam 1hssbabf
4 Feb 22
Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors
8:52am
8-K
EX-10.2
ezjx6uxdbco
4 Feb 22
Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors
8:52am
8-K
EX-10.1
yvbsdfxf eb8
4 Feb 22
Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors
8:52am
8-K
EX-10.2
lq6g2w
18 Jan 22
Departure of Directors or Certain Officers
4:27pm